Mammography Market To Reach USD 3.17 Billion By 2027 With CAGR of 8.9% | Reports and Data

Increasing demand for screening mammography in breast cancer screening coupled with high investments in the R&D of mammography systems are fueling the market growth.

The Global Mammography Market is forecast to reach USD 3.17 Billion by 2027, according to a new report by Reports and Data. Mammography is a specialized non-invasive medical imaging system that uses a low-energy based X-ray or ionizing radiation system to examine and see inside the human breasts. The produced images through the mammogram are analyzed for any abnormal findings inside the breasts. The global mammography market is growing at a substantial pace as the number of breast cancer patients and women with breast cancer risks & breast disorders are drastically being propelled. Breast cancer in the United States is the second most prominent cause of cancer death amongst women. The screening mammogram has been extensively popular in North American countries for early-stage detection of breast cancers.

Asia Pacific, with its elevated advancements in the healthcare industry and escalating volumes of breast cancer patients in China and India, is likely to achieve a significant market share by 2027. China and India are some of the fastest-growing markets, while the United States, Japan, and Germany hold some of the most prominent players in the market.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2617

Market Dynamics:

Increasing development of on-demand, digitally enabled, and seamlessly connected clinician-patient interactions to manage patient base is expected to drive pharma and healthcare market in the coming years. After the COVID-19 outbreak there has been a number of foundational shifts in the healthcare system. Some of the examples include increasing consumer involvement in health care decision-making, the rapid adoption of virtual health & other digital innovations, increasing focus on utilization of interoperable data & data analytics, and increased public-private collaborations in therapeutics and vaccine development. The increased public-private collaborations for vaccine development has arisen due to high pressure of regional governments. Health care providers, and other stakeholders have invested heavily to quickly pivot, adapt, and innovate therapeutics.

Surging demands and transition to patient-centric care delivery across geographies will change pharma and healthcare market trends through 2027.

Key participants include

Fujifilm Holdings Corporation, Carestream Health, Konica Minolta, Inc., Siemens AG, General Electric Company, Koninklijke Philips N.V., Canon Medical Systems Corporation, Analogic Corporation, Hologic, Inc., and BEMEMS Co., Ltd., among others.

Competitive Outlook:

The report focuses on current and emerging trends in the healthcare industry such as incorporation of IoT and Machine Learning to enhance efficiency of medical products. Top companies in the market are focusing on R&D activities to expand their product offerings and cater to unmet medical needs.

This report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, and recent developments in both historic and present contexts.

Further key findings from the report suggest

Online retailing supply of the radiological systems has been trendy in emerging nations like China and India mainly. Online retailers can offer reduced prices compared to the medical stores and offline vendors due to the non-involvement of the distributor chains in the business process. This sub-segment is expected to grow at a CAGR of 10.5% during the forecast period.

Computer-aided detection (CAD) in digital mammography has been successful in the advanced screening of abnormal tissues, masses, or calcification that might grow to cancerous cells. CAD systems help the radiologists notice those areas of abnormalities clearly.

Breast tomosynthesis is an advanced three-dimensional imaging mammography system that incorporates multiple images of the breast from various angles & positions and further synthesize them by the computer software into a three-dimensional image set to help obtain the best possible view of the tissue inside the breasts. Compared to the conventional 2D film based analog mammography or the 2D digital mammography, this mammogram offers 3D viewing system in a series of layers. Breast tomosynthesis is projected to grow the fastest with a CAGR of 12.0% throughout the forecast period 2019 to 2027.

Ambulatory surgery centers are modern kind of healthcare facility centers, which are focused on providing immediate surgical care and releasing the patients right after the surgery. The ambulatory surgery centers have a more convenient outpatient procedure alternative to the hospital-based inpatient systems, maintaining a strong track record of quality care. Ambulatory surgery centers, incorporating all the required and modern mammography systems, are expected to grow the fastest at a rate of 10.3% throughout the forecast period.

In July 2019, FUJIFILM Medical Systems U.S.A., Inc., launched its tomosynthesis Biopsy option for the ASPIRE Cristalle mammography system.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2617

For the purpose of this report, Reports and Data have segmented the global mammography market on the basis of type, sales channel, applications, technology, end-users, and region:

Type Outlook (Revenue, USD Billion; 2016-2027)

Screening Mammography

Diagnostic Mammography

Sales Channel Outlook (Revenue, USD Billion; 2016-2027)

Online Retailing

Medical Stores & Brand Outlet

Applications Outlook (Revenue, USD Billion; 2016-2027)

Breast Imaging

Stereotactic Biopsy

Technology Outlook (Revenue, USD Billion; 2016-2027)

Analog Mammography

Digital Mammography

Breast Tomosynthesis

Others

End-Users Outlook (Revenue, USD Billion; 2016-2027)

Hospitals

Diagnostic & Cancer Specialty Centers

Ambulatory Surgical Centers

Others

Regional Outlook (Revenue, USD Billion; 2016-2027)

North America

Europe

Asia Pacific

MEA

Latin America

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2617

Thank you for reading our report. To know more about the customization feature, please get in touch with us and our team will ensure the report is customized as per your requirements.   

Read More Reports:-

Epinephrine Market @ https://www.biospace.com/article/epinephrine-market-size-to-reach-usd-4-76-billion-in-2028-says-reports-and-data/

Fibrinogen Concentrate Market @ https://www.biospace.com/article/fibrinogen-concentrate-market-size-to-reach-usd-4-19-billion-in-2028-says-reports-and-data-/

Biopsy Devices Market @ https://www.biospace.com/article/biopsy-devices-market-size-to-reach-usd-3-69-billion-in-2028-noted-reports-and-data/

Creatinine Measurement Market @ https://www.biospace.com/article/creatinine-measurement-market-size-to-value-at-usd-841-01-million-in-2028/

Point of Care Glucose Testing Market @ https://www.biospace.com/article/point-of-care-glucose-testing-market-size-to-reach-usd-8-17-billion-in-2028-says-reports-and-data-/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Information:

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com